Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7Lymphoid 6Gastrointestinal 6Other solid neoplasm 5Other hematologic neoplasm 5CNS 4Sarcoma 3Thoracic 2Plasma cell 2Myeloid 2Head & Neck 2Dermatologic 2Tumor-Agnostic 1Gynecologic 1Genitourinary 1

Conditions

Neoplasms 1

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pharmacogenomic Testing × Tumor-Agnostic × Clear all
NCT06744712 2026-03-25

Pharmacogenomic Testing in Pediatric Hematology/Oncology Patients

Wake Forest University Health Sciences

Phase NA Not yet recruiting
130 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡